Clinical Trials
14 trialsNCT00005996 2013-12-19
SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00243100 2013-12-16
Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00020644 2013-08-07
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00004090 2013-07-10
Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00072228 2013-07-10
Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Withdrawn
NCT00072436 2013-07-02
Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00047047 2013-06-04
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00007917 2013-02-28
Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004242 2013-02-11
Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00079352 2013-01-25
Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00078962 2013-01-24
GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004063 2009-04-30
Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00043095 2008-07-24
BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00274859 2008-07-24
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Phase 2 Unknown